SCHEMBL19081631

SCHEMBL19081631

c1ccc(-c2c3ccccc3c(-c3ccc4cc(-c5cc6c7ccccc7oc6c6c5oc5cc7ccccc7cc56)ccc4c3)c3ccccc23)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
HSD17B10 Q99714 4/20 0.37
MAPT P10636 3/20 0.37
GAA P10253 2/20 0.37
HPGD P15428 2/20 0.37
CASP7 P55210 2/20 0.37
ALOX5 P09917 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALPI P09923 1/20 0.37
PKM P14618 1/20 0.37
CASP3 P42574 1/20 0.37
RECQL P46063 1/20 0.37
BLM P54132 1/20 0.37
CASP6 P55212 1/20 0.37
MCL1 Q07820 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081597 0.95 ALOX5 (0.38) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL19081578 0.95 KDM4E (0.37) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL19081503 0.94 KDM4E (0.39) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL17945327 0.93 ALOX5 (0.40) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL19081475 0.92 KDM4E (0.38) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL19081668 0.91 ALOX5 (0.39) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL10122326 0.90 GPR84 (0.40) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL10122300 0.89 ALOX5 (0.40) KDM4EHSD17B10MAPTHPGDCASP7
SCHEMBL10122258 0.89 GPR84 (0.37) KDM4EHSD17B10MAPTGAAHPGD
SCHEMBL10122320 0.88 ALOX5 (0.38) KDM4EHSD17B10MAPTGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 KDM4E 3720/4885HSD17B10 1824/4885MAPT 1294/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 KDM4E 3720/4885HSD17B10 1824/4885MAPT 1294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.